Original ResearchPublished 12 October 2026Physiologically-based pharmacokinetic model to predict pharmacokinetics of KY0467 in humans and guide dose selection in infants and childrenPanpan Xie · Yanyan Yang · Xuemei He · Ming Yang · Zhixing Chen · Xi Weng · Aixin ShiFrontiers in Pharmacologydoi 10.3389/fphar.2026.1866331
CorrectionPublished 7 October 2026Correction: Multi-homosubunit dsRNA/ dsDNA virus genome packaging nanomotors with sequential revolving mechanisms for potent drug developmentFrontiers Production OfficeFrontiers in RNA Researchdoi 10.3389/frnar.2026.2009050
ReviewPublished 3 September 2026Multi-homosubunit dsRNA/dsDNA virus genome packaging nanomotors with sequential revolving mechanisms for potent drug developmentMargaret Bohmer · Justin Gnarra · Daniel W. Binzel · Tao Weitao · Peixuan GuoFrontiers in RNA Researchdoi 10.3389/frnar.2026.1870177
ReviewPublished 30 July 2026Beyond one drug–one target: AI-guided discovery of multi-target antiviral therapeuticsVrinda Gupta · Sahil Sharma · Vikrant Abbot · Rohit Bhatia · Neeraj Choudhary · Dinesh KumarFrontiers in Virologydoi 10.3389/fviro.2026.1853552
Mini ReviewPublished 9 July 2026Computational screening of plant-derived compounds against SARS-CoV-2: methodological trends, limitations, and opportunitiesAlejandra Ojeda-Pérez · Rocío Borges-Argáez · Norberto Sánchez-CruzFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1882806
Mini ReviewPublished 25 June 2026The application of CRISPR gene-editing technology in influenza prevention and controlXinyi Zhang · Hangyi Shi · Jianlan Yang · Lailing Du · Xinling Zhang · Xiaoping LiFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1844919
Original ResearchPublished 11 June 2026Computational analysis and validation of UGT1A1/4 missense variants impacting tecovirimat metabolism in monkeypox patientsAmro A. Abdelazim · Sameh E. Hassanein · Mohamad Maged · Nada S. Al-Theyab · Itoh Kimiko · Kotb A. AttiaFrontiers in Systems Biologydoi 10.3389/fsysb.2026.1821230
